The Immune System – Products

In a significant stride towards advancing nanoparticle drug delivery manufacturing technology, German pharmatech company, leon-nanodrugs GmbH (LEON), proudly announces a pioneering technical evaluation by CMAC, University of Strathclyde.

Breakthrough medium delivers speed and scale to CAR-T cell therapy manufacturers.

First commercial source of on-demand GMP CD34+ hematopoietic stem cells for clinical manufacturing in the industry. OrganaBio leveraging years of in-house tissue sourcing and cell isolation experience to produce high-quality GMP-compliant cells.

The UK’s Medical Research Council is funding a 10-patient Phase I study to deliver rapid personalised treatment for lung cancer patients.

This application note showcases an automated immunoassay platform which surpasses the capabilities of ELISAs for single- or multi-analyte quantitation in biological matrices.

This application note explores an optimized RNA-sequencing workflow that reliably determines cell subset abundance and cell-type-specific gene expression profiles from bulk tissue or blood expression data.

This application note explores the performance characteristics of a tissue panel for profiling both FF and FFPE tissue samples using a state-of-the-art software solution for digital cytometry.

As of March 2024, the FDA has approved three CD20 × CD3 BsAbs: mosunetuzumab (Lunsumio) for relapsed or refractory follicular lymphoma (R/R FL), glofitamab (Columvi) for relapsed or refractory diffuse B cell lymphoma

Click here for further information!

resDetect™ is a series of reagent kits designed to follow international legal and regulatory requirements and guidelines for the detection of residual components in the biopharmaceutical manufacturing process.